There must be a HC reader who understands take-overs. It would be very nice to see very informed comment.
For a stock that is supposed to increase sp by around 50% with great possibility to be much more, who would be interested? Daiichi-Sanko might be a possibility, given that last year they purchased a private biotech company for around A$300 million.
Would the money be on GSK, Roche or DS? Are there others who might be interested?
In Australia, take-over offers seem to be initially at a 20% premium to last trade. Would this be likely for a volatile stock like BTA?
- Forums
- ASX - By Stock
- take-over taget
There must be a HC reader who understands take-overs. It would...
-
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)